-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – S-65487 in Marginal Zone B-cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - S-65487 in Marginal Zone B-cell Lymphoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. S-65487 in Marginal Zone B-cell Lymphoma Drug Details: S-65487...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – S-65487 in Diffuse Large B-Cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - S-65487 in Diffuse Large B-Cell Lymphoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. S-65487 in Diffuse Large B-Cell Lymphoma Drug Details: S-65487...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Maveropepimut-s in Diffuse Large B-Cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Maveropepimut-s in Diffuse Large B-Cell Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Maveropepimut-s in Diffuse Large B-Cell Lymphoma Drug Details: Maveropepimut-s (DPX-Survivac)...
-
Sector Analysis
NewUnited Kingdom (UK) Home Kitchen Textiles Market Trends, Analysis, Consumer Dynamics and Spending Habits
The UK: Home Category Data, The Consumer - Kitchen Textiles 2024 report offers a comprehensive insight into consumer attitudes in the UK kitchen textiles market. The report focuses on four key subcategories: kitchen towels, oven gloves, aprons and tea cosies. Consumer data is based on our 2024 UK kitchen textiles survey, using a panel of 2,000 nationally representative consumers.
-
Sector Analysis
NewUnited Kingdom (UK) Home Kitchen Storage Market Trends, Analysis, Consumer Dynamics and Spending Habits
The UK: Home Category Data, The Consumer - Kitchen Storage 2024 report offers a comprehensive insight into consumer attitudes in the UK kitchen storage market. The report focuses on four key subcategories: food storage, cleaning storage, storage racks, utensil storage. Consumer data is based on our 2024 UK kitchen storage survey, using a panel of 2,000 nationally representative consumers.
-
Sector Analysis
NewInferior Vena Cava Filters (IVCF) Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Inferior Vena Cava Filters (IVCF) Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Cardiovascular Devices therapeutic area. The model discusses in detail the impact of COVID-19 on the Inferior Vena Cava Filters market for the year 2020 and beyond. An inferior Vena Cava Filter (IVCF) is a type of vascular filter used to prevent blood clots from traveling to the lungs. The filter is inserted inside a large...
-
Company Insights
Innovation and Patenting activity of B&S Group SA Q1 2024
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of B&S Group SA Q1 2024". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – S-65487 in Diffuse Large B-Cell Lymphoma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. S-65487 in Diffuse Large B-Cell Lymphoma Drug Details: S-65487 is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – S-65487 in Marginal Zone B-cell Lymphoma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. S-65487 in Marginal Zone B-cell Lymphoma Drug Details: S-65487 is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – S-055746 in B-Cell Non-Hodgkin Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - S-055746 in B-Cell Non-Hodgkin Lymphoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. S-055746 in B-Cell Non-Hodgkin Lymphoma Drug Details: S-055746 is under...